Vascular Perfusion Solutions and Unravel Biosciences announce partnership to modulate endothelial activation during heart preservation to improve heart transplant outcomes
November 27, 2023 08:47 ET
|
Vascular Perfusion Solutions
BOSTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vascular Perfusion Solutions (VPS) and Unravel Biosciences, Inc. (“Unravel”) are partnering to develop a proprietary perfusion solution that will...
Vascular Perfusion Solutions Collaborates with Wyss Institute and U.S. Air Force to Study Compound to Improve Organ Transplant Outcomes
April 13, 2022 23:28 ET
|
Vascular Perfusion Solutions
SAN ANTONIO, April 13, 2022 (GLOBE NEWSWIRE) -- To enhance its research on extending the viability of organs outside the body for the purpose of organ transplant, Vascular Perfusion Solutions (VPS)...